Back to Market Feed

Product Information

ADAPALENE-BNZYL PEROX 0.1-2.5% is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3288 per GM under NDC 68462030147. Its NADAC has been published 344 times since Jan 22, 2020.

FDA first approved this application on Nov 8, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ADAPALENE-BNZYL PEROX 0.1-2.5%

adapalene and benzoyl peroxide
$0.3288per GM

Strength

1; 25 mg/g; mg/g

NDC

68462030147

Classification

Generic

Dosage Form

GEL

Route

TOPICAL

Effective Date

8/19/2026

Active Ingredients

ADAPALENE; BENZOYL PEROXIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA208108

FDA Approved

11/8/2019

TE Code

AB

On Market Since

11/8/2019

Pharmacological Classes

Retinoid
Retinoids

Price Statistics

The NADAC for ADAPALENE-BNZYL PEROX 0.1-2.5% has been published 344 times since Jan 22, 2020, and over the history we have for it it has declined 75.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3288 per GM
All-time high$1.3411 (Feb 12, 2020)
All-time low$0.2823 (Jul 22, 2026)
52-week high$0.4445
52-week low$0.2823
Median price$0.6592
Average price$0.7088
Largest weekly change+49.6% (May 17, 2023)
Weeks tracked344
Tracking sinceJan 22, 2020

Price History

1W

+16.5%

1M

+16.5%

3M

+11.5%

6M

+9.5%

1Y

-26.0%

3Y

-50.2%

5Y

-70.8%

All

-75.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

EPIDUO 0.1-2.5% GEL
Brand
00299590845•Galderma Laboratories, L.P.
$7.4842
+2176% more

Related Drugs

Same classification

ADAPALENE-BNZYL PEROX 0.1-2.5%
Generic
21922005250•Encube Ethicals, Inc.
$0.3288
per GM
ADAPALENE-BNZYL PEROX 0.1-2.5%
Generic
45802084601•Padagis Israel Pharmaceuticals Ltd
$0.3288
per GM
ADAPALENE-BNZYL PEROX 0.1-2.5%
Generic
51672136403•Sun Pharmaceutical Industries Inc.
$0.3288
per GM
ADAPALENE 0.1% GEL
Generic
00536141226•Rugby Laboratories
$0.3380
per GM
ADAPALENE 0.1% GEL
Generic
51672215006•Sun Pharmaceutical Industries Inc.
$0.3380
per GM
ADAPALENE 0.1% GEL
Generic
00536141220•Rugby Laboratories
$0.4670
per GM
GNP ADAPALENE 0.1% GEL
Generic
46122076836•AmerisourceBergen
$0.4670
per GM
ADAPALENE 0.1% GEL
Generic
51672215001•Sun Pharmaceutical Industries Inc.
$0.4670
per GM
TRETINOIN 0.025% CREAM
Generic
00378808245•Mylan Pharmaceuticals Inc.
$0.4684
per GM
TRETINOIN 0.025% CREAM
Generic
00472011745•Actavis Pharma, Inc.
$0.4684
per GM

Frequently asked questions

What is the NADAC price of ADAPALENE-BNZYL PEROX 0.1-2.5%?

The current National Average Drug Acquisition Cost (NADAC) for ADAPALENE-BNZYL PEROX 0.1-2.5%, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3288 per GM (NDC 68462030147), effective Aug 19, 2026.

How has the price of ADAPALENE-BNZYL PEROX 0.1-2.5% changed over time?

Over the history we have for it, the NADAC for ADAPALENE-BNZYL PEROX 0.1-2.5% has declined 75.5%. It has been tracked across 344 weekly CMS publications since Jan 22, 2020.

What are the highest and lowest recorded NADAC prices for ADAPALENE-BNZYL PEROX 0.1-2.5%?

Since Jan 22, 2020, the NADAC for ADAPALENE-BNZYL PEROX 0.1-2.5% has ranged from a low of $0.2823 (Jul 22, 2026) to a high of $1.3411 (Feb 12, 2020), with a median of $0.6592 per GM.

Are there cheaper alternatives to ADAPALENE-BNZYL PEROX 0.1-2.5%?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ADAPALENE-BNZYL PEROX 0.1-2.5% in a comparable dosage form, but none are currently priced below it.

Who manufactures ADAPALENE-BNZYL PEROX 0.1-2.5%?

ADAPALENE-BNZYL PEROX 0.1-2.5% (NDC 68462030147) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.